Lmr Partners LLP Amicus Therapeutics, Inc. Transaction History
Lmr Partners LLP
- $10.5 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding FOLD
# of Institutions
307Shares Held
332MCall Options Held
396KPut Options Held
249K-
Vanguard Group Inc Valley Forge, PA29.4MShares$266 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA29.1MShares$263 Million0.03% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$220 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY18MShares$163 Million1.88% of portfolio
-
William Blair Investment Management, LLC Chicago, IL14.6MShares$132 Million0.24% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.53B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...